Activated factor XI and tissue factor in aortic stenosis: Links with thrombin generation

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 6, 2011, Pages 473-479

  Luszczak, Joanna ^a   Undas, Anetta ^a   Gissel, Matthew ^b   Olszowska, Maria ^a   Butenas, Saulius ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

aortic stenosis; factor XIa; prothrombin fragment 1.2; tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 11; MONOCLONAL ANTIBODY; THROMBOPLASTIN;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; THROMBIN TIME;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FACTOR XIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTHROMBIN; SEVERITY OF ILLNESS INDEX; THROMBIN; THROMBOPLASTIN;

EID: 80052089569     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328346c2bb     Document Type: Article

References (30)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231-1243. (Pubitemid 36834640)
2. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343-349. (Pubitemid 36886240)
3. Stein PD, Sabbah HN, Pitha JV. Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow. Am J Cardiol 1977; 39:159-163. (Pubitemid 8043828)
4. Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 1998; 92:25-31.
5. Dimitrow PP, Hlawaty M, Undas A, Sniezek-Maciejewska M, Sobień B, Stepień E, et al. Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Atherosclerosis 2009; 204:103-108.
6. Dimitrow PP, Undas A, Bober M, Tracz W, Dubiel JS. Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart 2008; 94:e21.
7. Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: which? Where? When? Arterioscler Thromb Vasc Biol 2009; 29:1989-1996.
8. Steffel J, Lü scher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006; 113:722-731.
9. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991; 253:909-912. (Pubitemid 21917236)
10. Minnema MC, Peters RJ, de Winter R, Lubbers YP, Barzegar S, Bauer KA, et al. Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol 2000; 20:2489-2493.
11. Butenas S, Undas A, Gissel MT, Szuldrzynski K, Zmudka K, Mann KG. Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 2008; 99:142-149.
12. Jankowski M, Undas A, Kaczmarek P, Butenas S. Activated factor XI and tissue factor in chronic obstructive pulmonary disease: Links with inflammation and thrombin generation. Thromb Res 2011; 127:242-246.
13. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16:523-532. (Pubitemid 26107723)
14. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90:844-853. (Pubitemid 24242754)
15. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19:1218-1222. (Pubitemid 29227640)
16. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular AS in adults: literature review and clinical implications. Am Heart J 1996; 132:408-417. (Pubitemid 26292409)
17. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000; 101:2497-2502. (Pubitemid 30366254)
18. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001; 88:693-695. (Pubitemid 32831111)
19. Pate GE. Association between aortic stenosis and hypertension. J Heart Valve Dis 2002; 11:612-614.
20. Pohle K, Mäffert R, Ropers D, Moshage W, Stilianakis N, Daniel WG, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104:1927-1932. (Pubitemid 32983236)
21. Teirstein P, Yeager M, Yock PG, Popp RL. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. J Am Coll Cardiol 1986; 8:1059-1065. (Pubitemid 16009090)
22. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, Tow DE. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 1979; 60:760-766. (Pubitemid 10239332)
23. BaumgartnerH, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22:1-23.
24. Cawthern KM, van 't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91:4581-4592. (Pubitemid 28270306)
25. Marechaux S, Corseaux D, Vincentelli A, Richardson M, Ung A, Susen S, et al. Identification of tissue factor in experimental aortic valve sclerosis. Cardiovasc Pathol 2009; 18:67-76.
26. Natorska J, Marek G, Hlawaty M, Sobczyk D, Sadowski J, Tracz W, et al. Evidence for tissue factor expression in aortic valves in patients with aortic stenosis. Pol Arch Med Wewn 2009; 119:636-643.
27. Breyne J, Juthier F, Corseaux D, Marechaux S, Zawadzki C, Jeanpierre E, et al. Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis 2010; 213:369-376.
28. Dimitrow PP, Undas A. Letter regarding article 'Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction'. Circulation 2009; 119:e590.
29. Scott CF, Schapira M, James HL, Cohen AB, Colman RW. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest 1982; 69:844-852. (Pubitemid 12149162)
30. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230-268. (Pubitemid 46276943)